Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Relacorilant in Combination With Nab-Paclitaxel in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (RELIANT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04329949
Recruitment Status : Active, not recruiting
First Posted : April 1, 2020
Last Update Posted : February 1, 2021
Sponsor:
Information provided by (Responsible Party):
Corcept Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : January 2022